LENZ
Price
$12.88
Change
-$0.09 (-0.69%)
Updated
Feb 13 closing price
Capitalization
403.01M
Intraday BUY SELL Signals
RNAC
Price
$6.52
Change
+$0.11 (+1.72%)
Updated
Feb 13 closing price
Capitalization
170.32M
Intraday BUY SELL Signals
Interact to see
Advertisement

LENZ vs RNAC

Header iconLENZ vs RNAC Comparison
Open Charts LENZ vs RNACBanner chart's image
LENZ Therapeutics
Price$12.88
Change-$0.09 (-0.69%)
Volume$832.37K
Capitalization403.01M
Cartesian Therapeutics
Price$6.52
Change+$0.11 (+1.72%)
Volume$68.01K
Capitalization170.32M
LENZ vs RNAC Comparison Chart in %
LENZ
Daily Signal:
Gain/Loss:
RNAC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LENZ vs. RNAC commentary
Feb 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a Hold and RNAC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 15, 2026
Stock price -- (LENZ: $12.88 vs. RNAC: $6.52)
Brand notoriety: LENZ and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 69% vs. RNAC: 44%
Market capitalization -- LENZ: $403.01M vs. RNAC: $170.32M
LENZ [@Biotechnology] is valued at $403.01M. RNAC’s [@Biotechnology] market capitalization is $170.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 1 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • LENZ’s FA Score: 1 green, 4 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, both LENZ and RNAC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 3 TA indicator(s) are bullish while RNAC’s TA Score has 4 bullish TA indicator(s).

  • LENZ’s TA Score: 3 bullish, 5 bearish.
  • RNAC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both LENZ and RNAC are a bad buy in the short-term.

Price Growth

LENZ (@Biotechnology) experienced а -9.42% price change this week, while RNAC (@Biotechnology) price change was +0.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.41%. For the same industry, the average monthly price growth was -4.89%, and the average quarterly price growth was +22.89%.

Industries' Descriptions

@Biotechnology (+2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($403M) has a higher market cap than RNAC($170M). LENZ has higher P/E ratio than RNAC: LENZ (48.03) vs RNAC (1.98). RNAC YTD gains are higher at: -9.570 vs. LENZ (-19.500). LENZ has higher annual earnings (EBITDA): -67.7M vs. RNAC (-121.9M). LENZ has more cash in the bank: 202M vs. RNAC (143M). LENZ has less debt than RNAC: LENZ (954K) vs RNAC (12.6M). LENZ has higher revenues than RNAC: LENZ (17.5M) vs RNAC (1.09M).
LENZRNACLENZ / RNAC
Capitalization403M170M237%
EBITDA-67.7M-121.9M56%
Gain YTD-19.500-9.570204%
P/E Ratio48.031.982,431%
Revenue17.5M1.09M1,604%
Total Cash202M143M141%
Total Debt954K12.6M8%
FUNDAMENTALS RATINGS
RNAC: Fundamental Ratings
RNAC
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
47
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LENZRNAC
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
83%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LENZ
Daily Signal:
Gain/Loss:
RNAC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGPHF1262.248.75
+0.70%
Partners Group Holding Zug Namen-Akt
KSKGF4.00N/A
N/A
Kingsgate Consolidated Ltd.
ALTB5.41N/A
N/A
Alpine Auto Brokers Inc
PBKC73.75-0.25
-0.34%
Pioneer Bankcorp Inc.
ONEI0.17-0.01
-3.84%
OneMeta Inc.

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been closely correlated with ARTV. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if LENZ jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-0.69%
ARTV - LENZ
87%
Closely correlated
+0.25%
VTGN - LENZ
83%
Closely correlated
-7.23%
TPST - LENZ
82%
Closely correlated
+2.16%
RZLT - LENZ
81%
Closely correlated
+5.79%
MREO - LENZ
81%
Closely correlated
-4.32%
More

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with TAOX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
+1.72%
TAOX - RNAC
91%
Closely correlated
+5.91%
PALI - RNAC
81%
Closely correlated
-0.57%
OCUL - RNAC
58%
Loosely correlated
-1.99%
LENZ - RNAC
54%
Loosely correlated
-0.69%
AGIO - RNAC
52%
Loosely correlated
-0.39%
More